Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
inactivated influenza vaccine (1 trial)
Trials (1 total)
Trial APIs (2 total)